The Indonesian government asks Globelics to help improve innovation systems

The most recent Globelics Conference (October 2016) hosted by the University of Padjadajaran in Bandung, Indonesia, caught the attention of the Government of Indonesia and during the conference a meeting between Globelics and representatives from the office of the Indonesian President and from several ministries and agencies was held. This meeting has now led to a request for future cooperation from the Indonesian Government. Especially the Ministry of Research, Technology and Higher Education is enthusiastic to continue seeking input from Globelics in improving the Indonesian innovation system.

Not only about new ideas, but also how to apply new ideas in practice

Bengt-Åke Lundvall, General Secretary of Globelics and Professor at Aalborg University, explains that the reason why the knowledge of the researchers of the Globelics network is appealing for governments in developing countries is because “the approach of Globelics is not just about making good quality science and good quality education, but also about how to transform this knowledge into practical use. This is what we mean by innovation.” Lundvall continues:

Related Content

This is a controversial and troubling question for nations and citizens (especially if they are feeling insecure). But daily reality brings more important questions than this: the need to find food, shelter, and preserve or improve one’s health. “Development” in the abstract is a little distracting if it doesn’t speak directly to these essential concerns. Are developed societies those with healthy citizens and residents?

Conferência Internacional "Public Policy for Oil and Gas"

A  successful dialogue on the oil and gas industry, energy and development, and what public policy must focus on

View full conference here



The discussion elaborated on themes from Smita Srinivas's Market Menagerie: Health and Development in Late Industrial States—a far-reaching analysis of technological advance and market regulation of the biotech and pharmaceutical industries in India, Brazil, China, Nigeria, and South Africa—as a springboard into the difficult responsibilities of reporting across media and cultural divides.